| Effect of genetic background on the dystrophic phenotype in mdx mice WD Coley, L Bogdanik, MC Vila, Q Yu, JH Van Der Meulen, ... Human molecular genetics 25 (1), 130-145, 2016 | 206 | 2016 |
| TGF-β–driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model DAG Mázala, JS Novak, MW Hogarth, M Nearing, P Adusumalli, CB Tully, ... JCI insight 5 (6), 2020 | 112 | 2020 |
| TNF-α-induced microRNAs control dystrophin expression in Becker muscular dystrophy AA Fiorillo, CR Heier, JS Novak, CB Tully, KJ Brown, K Uaesoontrachoon, ... Cell reports 12 (10), 1678-1690, 2015 | 88 | 2015 |
| Quantitative antisense screening and optimization for exon 51 skipping in Duchenne muscular dystrophy Y Echigoya, KRQ Lim, N Trieu, B Bao, BM Nichols, MC Vila, JS Novak, ... Molecular Therapy 25 (11), 2561-2572, 2017 | 77 | 2017 |
| Germline quality control: eEF2K stands guard to eliminate defective oocytes HP Chu, Y Liao, JS Novak, Z Hu, JJ Merkin, Y Shymkiv, BP Braeckman, ... Developmental cell 28 (5), 561-572, 2014 | 65 | 2014 |
| Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle JS Novak, MW Hogarth, JF Boehler, M Nearing, MC Vila, R Heredia, ... Nature communications 8 (1), 941, 2017 | 44 | 2017 |
| Effect of endurance exercise on microRNAs in myositis skeletal muscle—A randomized controlled study JF Boehler, MW Hogarth, MD Barberio, JS Novak, S Ghimbovschi, ... PLoS One 12 (8), e0183292, 2017 | 38 | 2017 |
| Mitochondrial dysfunction and role of harakiri in the pathogenesis of myositis JF Boehler, A Horn, JS Novak, N Li, S Ghimbovschi, IE Lundberg, ... The Journal of pathology 249 (2), 215-226, 2019 | 33 | 2019 |
| Elusive sources of variability of dystrophin rescue by exon skipping MC Vila, MB Klimek, JS Novak, S Rayavarapu, K Uaesoontrachoon, ... Skeletal muscle 5, 1-12, 2015 | 32 | 2015 |
| Morpholino‐induced exon skipping stimulates cell‐mediated and humoral responses to dystrophin in mdx mice MC Vila, JS Novak, M Benny Klimek, N Li, M Morales, AG Fritz, K Edwards, ... The Journal of pathology 248 (3), 339-351, 2019 | 20 | 2019 |
| Human muscle stem cells are refractory to aging JS Novak, DAG Mázala, M Nearing, R Hindupur, P Uapinyoying, ... Aging Cell 20 (7), e13411, 2021 | 19 | 2021 |
| Membrane repair deficit in facioscapulohumeral muscular dystrophy AJ Bittel, SC Sreetama, DC Bittel, A Horn, JS Novak, T Yokota, A Zhang, ... International Journal of Molecular Sciences 21 (15), 5575, 2020 | 19 | 2020 |
| Interrogation of dystrophin and dystroglycan complex protein turnover after exon skipping therapy JS Novak, R Spathis, UJ Dang, AA Fiorillo, R Hindupur, CB Tully, ... Journal of Neuromuscular Diseases 8 (s2), S383-S402, 2021 | 18 | 2021 |
| The macrophage as a Trojan horse for antisense oligonucleotide delivery JS Novak, JK Jaiswal, TA Partridge Expert opinion on therapeutic targets 22 (6), 463-466, 2018 | 14 | 2018 |
| Shorter phosphorodiamidate morpholino splice-switching oligonucleotides may increase exon-skipping efficacy in DMD U Akpulat, H Wang, K Becker, A Contreras, TA Partridge, JS Novak, ... Molecular Therapy-Nucleic Acids 13, 534-542, 2018 | 13 | 2018 |
| Validation of chemokine biomarkers in Duchenne muscular dystrophy M Ogundele, JS Zhang, MV Goswami, ML Barbieri, UJ Dang, JS Novak, ... Life 11 (8), 827, 2021 | 11 | 2021 |
| The X‐linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45–47 CR Heier, NM McCormack, CB Tully, JS Novak, BL Newell‐Stamper, ... Journal of cachexia, sarcopenia and muscle 14 (2), 940-954, 2023 | 9 | 2023 |
| Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD DAG Mázala, R Hindupur, YJ Moon, F Shaikh, IH Gamu, D Alladi, G Panci, ... Cell death discovery 9 (1), 224, 2023 | 8 | 2023 |
| Anoctamin 5 knockout mouse model recapitulates LGMD2L muscle pathology and offers insight into in vivo functional deficits G Thiruvengadam, SC Sreetama, K Charton, M Hogarth, JS Novak, ... Journal of Neuromuscular Diseases 8 (s2), S243-S255, 2021 | 8 | 2021 |
| Characterization of the dystrophin‐associated protein complex by mass spectrometry EH Canessa, R Spathis, JS Novak, A Beedle, K Nagaraju, L Bello, ... Mass spectrometry reviews 43 (1), 90-105, 2024 | 4 | 2024 |
